EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Use of High-Flow Nasal Cannula and Non-Invasive Mechanical Ventilation in the Management of COVID-19 Patients: A Prospective Study

Sumalatha Arunachala iD, Ashwaghosha Parthasarathi iD, Chetak Kadabasal Basavaraj iD, Sowmya Malamardi, Shreya Chandran, Hariharan Venkataraman, Mohammed Kaleem Ullah iD, Koustav Ganguly iD, Swapna Upadhyay iD, Padukudru Anand Mahesh iD

Viruses · 2023

DOI: 10.3390/v15091879 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Sumalatha Arunachala und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, JSS Medical College, JSS Academy of Higher Education and Research, Mysuru 570015, India. Hauptthemen laut MEDLINE: Respiratory Insufficiency, Noninvasive Ventilation, COVID-19, Respiratory Distress Syndrome. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIC NIH HHS, Swedish Heart-Lung Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-flow nasal cannula (HFNC) and ventilator-delivered non-invasive mechanical ventilation (NIV) were used to treat acute respiratory distress syndrome (ARDS) due to COVID-19 pneumonia, especially in low- and middle-income countries (LMICs), due to lack of ventilators and manpower resources despite the paucity of data regarding their efficacy. This prospective study aimed to analyse the efficacy of HFNC versus NIV in the management of COVID-19 ARDS. A total of 88 RT-PCR-confirmed COVID-19 patients with moderate ARDS were recruited. Linear regression and generalized estimating equations (GEEs) were used for trends in vital parameters over time. A total of 37 patients were on HFNC, and 51 were on NIV. Patients in the HFNC group stayed slightly but not significantly longer in the ICU as compared to their NIV counterparts (HFNC vs. NIV: 8.00 (4.0–12.0) days vs. 7.00 (2.0–12.0) days; p = 0.055). Intubation rates, complications, and mortality were similar in both groups. The switch to HFNC from NIV was 5.8%, while 37.8% required a switch to NIV from HFNC. The resolution of respiratory alkalosis was better with NIV. We conclude that in patients with COVID-19 pneumonia with moderate ARDS, the duration of treatment in the ICU, intubation rate, and mortality did not differ significantly with the use of HFNC or NIV for respiratory support.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory InsufficiencyNoninvasive VentilationCOVID-19Respiratory Distress SyndromeHumansCannulaRespiration, ArtificialProspective Studies

Stichwörter der Autor:innen

ARDSCOVID-19high-flow nasal cannulanon-invasive mechanical ventilationpneumonia

Autor:innen und Institutionen

  • Department of Respiratory Medicine, JSS Medical College, JSS Academy of Higher Education and Research, Mysuru 570015, India.
  • Public Health Research Institute of India, Mysuru 570020, India.
  • Allergy, Asthma, and Chest Centre, Krishnamurthy Puram, Mysuru 570004, India.
  • RUTGERS Centre for Pharmacoepidemiology and Treatment Science, New Brunswick, NJ 08901, USA.
  • School of Psychology & Public Health, College of Science Health and Engineering, La Trobe University, Melbourne, VIC 3086, Australia.
  • Centre for Excellence in Molecular Biology and Regenerative Medicine (A DST-FIST Supported Center), Department of Biochemistry (A DST-FIST Supported Department), JSS Medical College, JSS Academy of Higher Education and…

ORCID-Profile: Sumalatha Arunachala, Ashwaghosha Parthasarathi, Chetak Kadabasal Basavaraj, Mohammed Kaleem Ullah, Koustav Ganguly, Swapna Upadhyay, Padukudru Anand Mahesh

Förderung

  • FIC NIH HHS
  • Swedish Heart-Lung Foundation

Zitieren

APA

Arunachala, S., Parthasarathi, A., Basavaraj, C. K., Malamardi, S., Chandran, S., Venkataraman, H., Ullah, M. K., Ganguly, K., Upadhyay, S., & Mahesh, P. A. (2023). The Use of High-Flow Nasal Cannula and Non-Invasive Mechanical Ventilation in the Management of COVID-19 Patients: A Prospective Study. Viruses. https://doi.org/10.3390/v15091879

Vancouver

Arunachala S, Parthasarathi A, Basavaraj CK, Malamardi S, Chandran S, Venkataraman H, et al. The Use of High-Flow Nasal Cannula and Non-Invasive Mechanical Ventilation in the Management of COVID-19 Patients: A Prospective Study. Viruses. 2023. doi:10.3390/v15091879

BibTeX
@article{Arunachala2023,
  author = {Arunachala, Sumalatha and Parthasarathi, Ashwaghosha and Basavaraj, Chetak Kadabasal and Malamardi, Sowmya and Chandran, Shreya and Venkataraman, Hariharan and Ullah, Mohammed Kaleem and Ganguly, Koustav and Upadhyay, Swapna and Mahesh, Padukudru Anand},
  title = {The Use of High-Flow Nasal Cannula and Non-Invasive Mechanical Ventilation in the Management of COVID-19 Patients: A Prospective Study},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15091879}
}
Kostenlos starten →